HTG Molecular Announces Amendment to Second Statement of Work with QIAGEN Manchester Limited

TUCSON, Ariz. , Aug. 09, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has entered into an amendment to the second statement of work (“SOW Two”) under